Antibody-drug conjugates in breast cancer: Progress and future directions
Summary: Antibody-drug conjugates (ADCs) have transformed the treatment landscape of breast cancer, enabling targeted delivery of potent cytotoxic payloads to antigen-expressing tumor cells. These agents have demonstrated efficacy across breast cancer subtypes, including chemotherapy-refractory dise...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2026-05-01
|
| Edice: | Cell Reports Medicine |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S266637912600159X |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|